Efficacy and Safety of GLP1RAs in Liver-Transplanted People with Diabetes-Ad Interim Results of a 24-Month Trial

被引：0
|
作者：
Grancini, Valeria
Cogliati, Irene
Gaglio, Alessia
Resi, Veronica
Orsi, Emanuela
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-769-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
769-P
引用
收藏
页数：2
相关论文
共 37 条
  • [1] Efficacy and safety of GLP1RAs in liver-transplanted patients with diabetes: a 12 months follow up evaluation
    Grancini, V.
    Cogliati, I.
    Gaglio, A.
    Resi, V.
    Orsi, E.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S330 - S330
  • [2] Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyria: 24-Month Interim Analysis of the Phase 3 ENVISION Randomized Clinical Trial
    Bonkovsky, Herbert L.
    Ventura, Paolo
    Gouya, Laurent
    Peiro, Paula Aguilera
    Bissell, Montgomery
    Stein, Penelope E.
    Anderson, Karl E.
    Monroy, Susana
    Kuter, David J.
    Oh, Jeeyoung
    Ko, John J.
    Hua, Zhaowei
    Sweetser, Marianne T.
    Sardh, Eliane
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S545 - S546
  • [3] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Lieske, John
    Groothoff, Jaap
    Frishberg, Yaacov
    Sellier-Leclerc, Anne-Laure
    Shasha-Lavsky, Hadas
    Saland, Jeffrey
    Hayes, Wesley
    Magen, Daniella
    Moochhala, Shabbir
    Coenen, Martin
    Simkova, Eva
    Ngo, Taylor
    Gansner, John
    Hulton, Sally-Anne
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S1 - S2
  • [4] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
    Lieske, John
    Groothoff, Jaap
    Frishberg, Yaacov
    Sellier-Leclerc, Anne-Laure
    Shasha-Lavsky, Hadas
    Saland, Jeffrey
    Hayes, Wesley
    Magen, Daniella
    Moochhala, Shabbir
    Coenen, Martin
    Simkova, Eva
    Ngo, Taylor
    Gansner, John
    Hulton, Sally-Anne
    JOURNAL OF UROLOGY, 2022, 207 (05): : E87 - E87
  • [5] A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
    Langdahl, Bente L.
    Teglbjaerg, Christence Stubbe
    Ho, Pei-Ran
    Chapurlat, Roland
    Czerwinski, Edward
    Kendler, David L.
    Reginster, Jean-Yves
    Kivitz, Alan
    Lewiecki, E. Michael
    Miller, Paul D.
    Bolognese, Michael A.
    McClung, Michael R.
    Bone, Henry G.
    Ljunggren, Osten
    Abrahamsen, Bo
    Gruntmanis, Ugis
    Yang, Yu-Ching
    Wagman, Rachel B.
    Mirza, Faisal
    Siddhanti, Suresh
    Orwoll, Eric
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04): : 1335 - 1342
  • [6] Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
    Schena, Francesco P.
    Pascoe, Michael D.
    Alberu, Josefina
    del Carmen Rial, Maria
    Oberbauer, Rainer
    Brennan, Daniel C.
    Campistol, Josep M.
    Racusen, Lorraine
    Polinsky, Martin S.
    Goldberg-Alberts, Robert
    Li, Huihua
    Scarola, Joseph
    Neylan, John F.
    TRANSPLANTATION, 2009, 87 (02) : 233 - 242
  • [7] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [8] Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation Study
    Lapierre, Ariane
    Badet, Lionel
    Rouviere, Olivier
    Crehange, Gilles
    Berthiller, Julien
    Paparel, Philippe
    Chapet, Olivier
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (01) : e73 - e79
  • [9] Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results
    Yang, Paul
    Birch, David
    Lauer, Andreas
    Sisk, Robert
    Anand, Rajiv
    Pennesi, Mark E.
    Iannaccone, Alessandro
    Yaghy, Antonio
    Scaria, Abraham
    Jung, Jung Ah
    Curtiss, Darin
    Waheed, Nadia K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 271 : 268 - 285
  • [10] Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
    Cohen, Jeffrey A.
    Comi, Giancarlo
    SeImaj, Krzysztof W.
    Bar-Or, Amit
    Arnold, Douglas L.
    Steinman, Lawrence
    Hartung, Hans-Peter
    Montalban, Xavier
    Havrdova, Eva Kubota
    Cree, Bruce A. C.
    Sheffield, James K.
    Minton, Neil
    Raghupathi, Kartik
    Huang, Vivian
    Kappos, Ludwig
    LANCET NEUROLOGY, 2019, 18 (11): : 1021 - 1033
1234